Bookmark

Add to MyYahoo RSS

Biotech News

Biotech news continually updated from thousands of sources around the net.

3 hrs ago | The Washington Post

Lilly First-Quarter Profit Matches Analysts' Estimates

Eli Lilly & Co., the drugmaker in its worst year of declining sales, reported profit that matched analysts' estimates as gains from its animal health unit helped offset declining pharmaceutical revenue.

Comment?

Related Topix: Eli Lilly, Medicine, Healthcare Industry, Business News

7 hrs ago | KOLD-TV Tucson

Vermont ups the ante on genetically modified foods

Vermont has raised the stakes in the debate over genetically modified foods by becoming the first state to pass a bill requiring that they be labeled as such in the grocery aisle, making the move despite the opposition of the powerful U.S. food industry.

Comment?

Related Topix: Vermont, Vermont Government, Agriculture, Science, Science / Technology, US Governors, Peter Shumlin

9 hrs ago | Greenwich Citizen

New drug sales help boost Novartis Q1 profit

The Jan. 29, 2014 file photo shows Novartis CEO Joseph Jimenez as he arrives for the annual balance press conference in Basel, Switzerland.

Comment?

Related Topix: Novartis, Noven Pharmaceuticals

13 hrs ago | SFGate

Arkansas court won't reconsider Risperdal case

The Arkansas Supreme Court on Thursday declined to reconsider its decision that threw out a $1.2 billion judgment against a pharmaceutical company accused of improperly marketing an antipsychotic drug.

Comment?

Related Topix: Arkansas, Johnson & Johnson, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, VisionCare Ophthalmic Technologies, Startups

18 hrs ago | WAFF-TV Huntsville

More

A federal health official is scheduled to speak about the state's rising infant mortality rate at Alabama State University.

Comment?

Related Topix: Alabama State University, National Institutes of Health, Medicine, Healthcare Industry

22 hrs ago | Newindpress

Novartis Reports Q1 Profit up on Divestitures

Swiss pharmaceutical company Novartis AG has reported a 24 percent increase in profit for the first quarter, helped by selling off less-profitable parts of its business.

Comment?

Related Topix: Noven Pharmaceuticals

Wed Apr 23, 2014

The Day

Malloy touts business ties at chamber breakfast

Gov. Dannel P. Malloy, making an appearance at a Chamber of Commerce of Eastern Connecticut breakfast Wednesday at the Mystic Marriott while fighting allergies and a cold, touted his relationships with the business community, including discussions at high levels of Pfizer Inc. that led to the donation this month of a building to house a bioscience ... (more)

Comment?

Related Topix: Mystic, CT, Pfizer, Medicine, Healthcare Industry, Groton, CT

WGBH

Costly Hepatitis C Pill Shreds Drug Industry Sales Record

The launch of Sovaldi, the $1,000-a-day pill for hepatitis C, is shaping up as the most successful ever.

Comment?

Related Topix: Hepatitis, Medicine, Health, Food and Drug Administration, Gilead Sciences, Healthcare Industry, Startups

National Institutes of Health

NIH scientist to receive Ross Prize in Molecular Medicine

John J. O'Shea, M.D., scientific director at the National Institute of Arthritis and Musculoskeletal and Skin Diseases , has been named the 2014 recipient of the Ross Prize in Molecular Medicine, conferred by the Feinstein Institute's peer-reviewed, open-access journal Molecular Medicine.

Comment?

Related Topix: National Institutes of Health, Medicine, Healthcare Industry, Immunology, Biology, Science, Genetics, Saint Lawrence University, Canton, NY

WATE-TV Knoxville

Gacy case helps solve unrelated Chicago area death

EDITOR'S NOTE: In 1981, the U.S. Centers for Disease Control and Prevention reported the first cases of a rare pneumonia that had sickened five Los Angeles gay men.

Comment?

Related Topix: Centers for Disease Control and Prevention, Medicine, Healthcare Industry, Epidemic, Natural Disasters, Air Accidents

Sunherald.com

US stocks edge lower after a six-day rally

Intuitive Surgical was among those reporting disappointed results. A worse-than-expected report on the housing market also weighed on the broader market.

Comment?

Related Topix: Financial Markets, Startups, Intuitive Surgical, Robots, Medicine, Gilead Sciences, Healthcare Industry

Prince George Citizen

3 Valeant directors won't be standing for re-election, citing time required

Valeant Pharmaceuticals International, Inc. says three of its directors will not stand for re-election this year, citing increased demands on their time and possible conflicts of interest in the future.

Comment?

Related Topix: Valeant Pharmaceuticals International

Lincoln Daily News

Valeant CEO 'disappointed' in Allergan poison pill: CNBC

T he chief executive officer of Valeant Pharmaceuticals, which made a $47 billion unsolicited offer for competitor Allergan Inc. on Tuesday, said during an interview on CNBC that he was "disappointed" with Allergan's so-called poison pill.

Comment?

Related Topix: Allergan

MarketWatch

After Hours: Gilead shares climb; AT&T, Amgen shares fall

Gilead Sciences Inc., AT&T Inc. and Amgen Inc. were among the stocks actively trading Tuesday evening, with shares of Gilead climbing after handily beating Wall Street's quarterly earnings and revenue expectations and reporting a sales surge for its new hepatitis C treatment.

Comment?

Related Topix: Medicine, Amgen, Healthcare Industry, Gilead Sciences, Cable & Satellite, Telecom, ATT, Startups, Financial Markets, Hepatitis, Health

Tue Apr 22, 2014

The Campbell Reporter

Biz Break: Gilead's new hepatitis C drug produces huge sales in debut quarter

Today: Gilead Sciences demolishes earnings expectations thanks to powerful sales of breakthrough hepatitis C drug Sovaldi.

Comment?

Related Topix: Medicine, Gilead Sciences, Healthcare Industry, Startups, CGI Pharmaceuticals, Intuitive Surgical, Netflix, Telecom, Juniper Networks, Computers

Iol.co.za

Earnings give Wall Street sixth straight gain

US stocks rose on Tuesday as a host of solid earnings reports, along with strength in the healthcare sector, helped lift the S&P 500 and Nasdaq to their sixth straight advance.

Comment?

Related Topix: Financial Markets, Allergan, Vicept Therapeutics, Valeant Pharmaceuticals International

SFGate

Biotech Company Gilead Just Destroyed All Expectations For Sales Of Its New Hepatitis C Drug

Gilead Sciences is among the big biotech companies that have seen their shares whipsaw in the recent sell-off in biotech stocks .

Comment?

Related Topix: Medicine, Gilead Sciences, Healthcare Industry, Startups, CGI Pharmaceuticals, Business News

Daily Journal

Pharma deals give stocks a lift

Amid a relative dearth of economic data and the lack of fresh news in Ukraine, investors are focusing on the latest batch of U.S. corporate earnings and the slew of developments in the pharmaceuticals industry.

Comment?

Related Topix: Financial Markets, Medicine, GlaxoSmithKline, Healthcare Industry

Asbury Park Press

Exec at Bridgewater-based drug firm gets 16 months in inside-trade case

A former pharmaceutical executive has been sentenced to 15 months in prison for his role in an insider trading scheme.

Comment?

Related Topix: Celgene, Medicine, Healthcare Industry

Bellingham Herald

Amgen misses 1Q views as higher costs cut profit

The company badly missed Wall Street's expectations for both earnings per share and revenue, sending down its shares.

Comment?

Related Topix: Medicine, Amgen, Healthcare Industry, Osteoporosis, Health

•••
•••
•••
•••

Biotech Jobs

•••
•••
•••
•••
•••